Vitiligo Clinical Trials Vitiligo RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Secukinumab in Active Non-segmental Vitiligo
Conditions:   Vitiligo;   Secukinumab Intervention:   Drug: Secukinumab Sponsors:   University Hospital, Ghent;   Novartis Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2023 Category: Research Source Type: clinical trials